Home

CVS Health Corporation - Financial Overview

Ticker - CVS

Close PriceMarket CapP/E RatioForward P/E RatioImplied Growth*Implied Forward Growth*P/B Ratio
$63.58$80.43B15.29.88.8%4.3%1.0

Revenue and Net Income Chart EPS Chart
  Date Revenue Net Income EPS Revenue Change Net Income Change EPS Change
0 2020-12-31 $268.7B $7.2B $5.48 N/A N/A N/A
1 2021-12-31 $292.1B $8.0B $6.00 8.7% 11.5% 9.5%
2 2022-12-31 $322.5B $4.3B $3.29 10.4% -46.1% -45.2%
3 2023-12-31 $357.8B $8.3B $6.49 10.9% 93.6% 97.3%
4 2024-12-31 $372.8B $4.6B $3.67 4.2% -44.7% -43.5%
5 TTM 2025-03-31 $379.0B $5.3B $4.19 1.6% 14.4% 14.2%
6 Average 7.2% 5.7% 6.5%




CVS - Forecast Data



CVS - Y/Y % Change

  Metric Value
0 Total Assets $255,585M
1 Cash $10,076M
2 Total Liabilities $178,475M
3 Total Debt $81,213M
4 Total Equity $76,929M
5 Debt to Equity Ratio 1.06
CVS Balance Sheet Chart


CVS - Expense Overview



CVS - Unmapped Expense Line Items

No unmapped expenses.



CVS - Valuation Chart


Valuation Chart

Share Price Treasury Yield Estimates Fair Value (P/E) Fair Value (P/S) Current P/S Current P/E
$63.58 4.5% Nicks Growth: 5%
Nick's Expected Margin: 2%
FINVIZ Growth: 14%
Nicks: 11
Finviz: 24
Nick's: 0.210 0.2 15.2
Basis Year Nicks Valuation Nicks vs Share Price Finviz Valuation Finviz vs Share Price
$4.19 EPS TTM $44.00 -30.8% $101.77 60.1%
$6.10 EPS 2025 $64.06 0.8% $148.16 133.0%
$6.98 EPS 2026 $73.30 15.3% $169.54 166.7%